/PRNewswire/ THC is perhaps the most well-known cannabinoid within cannabis. THC, short for tetrahydrocannabinol, is famously responsible for cannabis s.
By Syndicated Content
By Shariq Khan
(Reuters) - The U.S. cannabis industry is hoping that the fourth time is a charm for a major banking reform bill that is once again headed to the Senate for approval after a comfortable victory in the U.S. House of Representatives.
The House voted 321-101 on Monday to approve a legislation that would allow banks to provide services to cannabis companies in states where it is legal.
The bill states that proceeds from legitimate cannabis businesses would not be considered illegal and directs federal regulators to craft rules for how they would supervise such banking activity.
Share:
The U.S. House of Representatives passed legislation on Monday to allow banks to provide services to cannabis companies in states where it is legal.
Republicans are increasingly warming up to adult-use cannabis legalization given the jobs and tax revenue opportunities, Cowen Inc. analyst Vivien Azer said Tuesday on CNBC s Squawk On The Street.
As more states move toward legalization of cannabis, the analyst said she likes three U.S names in particular. Our best idea is
The analyst also has Outperform ratings on
Curaleaf Holdings Inc (OTC: CURLF) and
Trulieve Cannabis Corp (OTC: TCNNF).
With the growing number of medical cannabis patients in Ohio, the state decided to more than double the number of medical marijuana dispensaries in the following year, reports The (Cincinnati) Enquirer.
The Ohio Board of Pharmacy approved the expansion Monday, enabling companies to apply for 73 new dispensary licenses this summer, bringing the total to 130 across the state.
Applicants are supposed to follow the original rules from 2017, which count security and business plan requirements, the report stated. The businesses would be limited to five dispensary licenses in the state, including the ones already in existence.
The first limit on the number of dispensaries in the state was set to 60 by the pharmacy board in 2017, and was based on a projected patients count of around 12,000 and 24,000 over two years, according to Sharon Maerten-Moore, the board’s director of medical marijuana operations.